Application 202266
- Type
- ANDA
- Sponsor
- CELLTRION
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | TABLET;ORAL | EQ 75MG BASE | No | No |
| 002 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | TABLET;ORAL | EQ 300MG BASE | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202266-001 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | ||
| A202266-002 | CLOPIDOGREL BISULFATE | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 5d02ea3f76ae… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 4b0b4de00fa7… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | AB | 2012-08-14 | 74a2ff9319b5… | |
| 2019-12-13 00:20 UTC | 2019-12 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | AB | 2012-11-20 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202266-001 | CLOPIDOGREL BISULFATE | EQ 75MG BASE | TABLET / ORAL | 2012-08-14 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202266-002 | CLOPIDOGREL BISULFATE | EQ 300MG BASE | TABLET / ORAL | 2012-11-20 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | A202266-001 | AB | 1 | 74a2ff9319b5… |
| 2019-12-13 00:20 UTC | 2019-12 | A202266-002 | AB | 1 | 74a2ff9319b5… |
| 2019-12-14 00:12 UTC | 2019-12 | A202266-001 | AB | 1 | 3f01610625f2… |
| 2019-12-14 00:12 UTC | 2019-12 | A202266-002 | AB | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202266-001 | AB | 1 | b00525d2431f… |
| 2019-09-15 20:21 UTC | 2019-09 | A202266-002 | AB | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202266-001 | AB | 1 | ea99ee380514… |
| 2019-07-19 19:46 UTC | 2019-07 | A202266-002 | AB | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals Inc. | c9928956-bb7b-4ec2-bc38-d3c9c4199cae | 2026-07-24 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 3e2539c1-a6ad-4d60-944c-c2e7aa70ce45 | 2026-07-15 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | e5ee3807-5c9d-4b65-b188-4159a0fb1c85 | 2026-06-23 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Ascend Laboratories, LLC | db1161c9-6efd-4361-a766-6a37c241ccee | 2026-06-01 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Cardinal Health 107, LLC | c03a895c-2d74-4d7f-891f-b752ce409b68 | 2026-04-21 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Preferred Pharmaceuticals, Inc. | e51d4bcc-01df-409d-9179-45e6536ac25b | 2026-03-31 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Legacy Pharmaceutical Packaging, LLC | 53de10a5-dbd0-413d-90e5-00a1920ec391 | 2026-03-03 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 553b4938-4462-4aeb-e054-00144ff88e88 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | NuCare Pharmaceuticals,Inc. | 55530ff3-5ce4-120f-e054-00144ff8d46c | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | NCS HealthCare of KY, LLC dba Vangard Labs | 8406b8e3-e203-402f-8858-2748119e2351 | 2026-02-25 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | AvPAK | 94a5cdc4-e063-1d46-e053-2995a90a7e15 | 2026-01-14 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | Novadoz Pharmaceuticals LLC | 1447a095-c663-4f05-91d4-f09bfc0c3d42 | 2025-11-12 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | d072b6ea-2bb4-8965-918e-23f9080efcb0 | 2025-10-22 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Quallent Pharmaceuticals Health LLC | 333c7992-d481-b7d4-404f-9a49c85b6331 | 2025-10-14 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 2969deac-274b-4042-9c90-9522e62a979d | 2025-09-25 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Apotex Corp. | edae8df1-caf9-ff72-1304-5ae8b355f8e7 | 2025-09-17 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel | CLOPIDOGREL BISULFATE | Major Pharmaceuticals | 4cd07a3c-9673-4aa0-b76a-d79df2399ee1 | 2025-09-08 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | Dr.Reddy's Laboratories Limited | b5aa951f-72de-bea1-98a2-a4085c64a361 | 2025-08-28 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
| CLOPIDOGREL | CLOPIDOGREL BISULFATE | REMEDYREPACK INC. | 669f0bc6-f173-484d-8efe-c006683b25d1 | 2025-06-27 | Boxed warning, Warnings, Adverse reactions | CLOPIDOGREL BISULFATE |
| Clopidogrel bisulfate | CLOPIDOGREL BISULFATE | McKesson Corporation dba SKY Packaging | 823c5dd0-f4e6-9b45-54de-a609caa8fa90 | 2025-04-14 | Boxed warning, Warnings, Adverse reactions | Clopidogrel bisulfate CLOPIDOGREL BISULFATE |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 55648-314 | Clopidogrel | Clopidogrel | Wockhardt Limited | ANDA | Current |
| 55648-315 | Clopidogrel | Clopidogrel | Wockhardt Limited | ANDA | Current |
| 64679-314 | Clopidogrel | Clopidogrel | Wockhardt USA LLC. | ANDA | Current |
| 64679-315 | Clopidogrel | Clopidogrel | Wockhardt USA LLC. | ANDA | Current |